CEFA-TABS 1GM DIN 00844225
Health Canada record
| Active ingredient(s) | CEFADROXIL 1 G |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1990 |
| Current status date | 26-Aug-2004 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CEFADROXIL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02240774 | APO-CEFADROXIL | APOTEX INC | Capsule | CEFADROXIL 500 MG | Marketed |
| 02240600 | CEFADROXIL | APOTEX INC | Capsule | CEFADROXIL 500 MG | Approved |
| 00849413 | CEFA-DROPS 50MG/ML | AYERST LABORATORIES | Powder For Solution | CEFADROXIL 50 MG | Cancelled Post Market |
| 00507245 | DURICEF | BRISTOL-MYERS SQUIBB CANADA | Capsule | CEFADROXIL 500 MG | Cancelled Post Market |
| 02311062 | PRO-CEFADROXIL - 500 | PRO DOC LIMITEE | Capsule | CEFADROXIL 500 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 6700 | 1998-04-17 | New Drug Submission (NDS) |
International API supply for CEFADROXIL
5 active FDA Drug Master Files.
Request a quote for CEFA-TABS 1GM